49 results
Page 2 of 3
S-3
EX-4.8
frmc0b2uxg4i0hsiwwor
5 Aug 22
Shelf registration
5:08pm
8-K
EX-99.1
cd7bzb6 8c4
6 Jun 22
Regulation FD Disclosure
8:37am
8-K
EX-99.1
0k6vr0psufe
26 May 22
Candel Therapeutics Announces Release of Initial Data on CAN-2409 in a Phase 2 Clinical Trial Showing Cytotoxic T Cell Response and Disease Control in Patients with Non-Small Cell Lung Cancer
5:36pm
10-K
EX-4.2
omrov0q uqvca
29 Mar 22
Annual report
8:46am
10-K
EX-10.11
1clysg0l3vk0g8xx1vf
29 Mar 22
Annual report
8:46am
10-K
o81ps
29 Mar 22
Annual report
8:46am
10-Q
aesp snw5
8 Sep 21
Quarterly report
8:37am
8-K
EX-3.1
jgc8r1
30 Jul 21
Departure of Directors or Certain Officers
12:00am
8-K
EX-3.2
l103u7hab58693cw
30 Jul 21
Departure of Directors or Certain Officers
12:00am
424B4
f865fs8i
28 Jul 21
Prospectus supplement with pricing info
4:02pm
S-1/A
EX-4.4
9o7 bdsd1
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
plzgnd n6t3for1l
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-3.2
xuv7gw5
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-3.4
coojanbg6o
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-3.1
s2y7ivzyf3ii 7o21u78
16 Jul 21
IPO registration (amended)
6:07am
S-1/A
EX-10.2
ae8c0i5
16 Jul 21
IPO registration (amended)
6:07am